Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Tumor-Agnostic 1Sarcoma 1Head & Neck 1Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3

Interventions

Carboplatin 110pembrolizumab 92Pemetrexed 84Cisplatin 69Specimen Handling 40Paclitaxel 36durvalumab 35Docetaxel 34atezolizumab 33Nivolumab 33osimertinib 30Magnetic Resonance Spectroscopy 29Gemcitabine 22Radiotherapy 20Etoposide 20130-nm albumin-bound paclitaxel 19Cetuximab 16amivantamab 14Platinum 13Bevacizumab 13Radiosurgery 12Radiation 12lazertinib 11Taxes 11Ipilimumab 11Immunoglobulin G 11cemiplimab 10Topotecan 10Disulfides 101,2-diaminocyclohexaneplatinum II citrate 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Tiragolumab × Thoracic × 30 days × Clear all
NCT04513925 2026-06-03

SKYSCRAPER-03

Hoffmann-La Roche

Phase 3 Completed
829 enrolled 40 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04619797 2026-06-03

SKYSCRAPER-06

Hoffmann-La Roche

Phase 2/3 Completed
542 enrolled 28 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03337698 2026-05-12

Morpheus Lung

Hoffmann-La Roche

Phase 1/2 Terminated
314 enrolled 31 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡